Vitiligo is a disease that causes uneven discoloration (pigmentation) of the skin. Additionally, the hair on the skin areas may lose their color and appear white. The average age of onset of vitiligo is the mid-20s, but it can occur at any age. The size and type of plaques vary from person to person. This condition tends to disappear with large pore areas and loss of skin pigment. However, in some affected individuals, these plaques may remain constant or increase.
Scientists have identified various types of vitiligo. Generalized vitiligo (also known as non-segmental vitiligo) is the most common form and causes discoloration (depigmentation) in pores and patches of skin around the body. Depigmentation usually occurs on the face, neck, and scalp, as well as around the shaft opening, mouth, and genitals. Sometimes the color is displaced along with the lips on the mucous membrane. Loss of pigmentation also often occurs in areas of friction, blow, or other trauma, including the arms, legs, and bones (bone spurs) close to the skin. All other forms of this condition (called segmental vitiligo) are associated with small patches of depigmented skin that appear in one area of the frame. This appearance is seen in approximately 10% of affected individuals.
Vitiligo is a condition that causes partial color loss (pigmentation) in the pores and skin. Likewise, the pores and hair in the skin areas may lose their color and appear white. The average age of onset of vitiligo is the mid-1920s, but it can occur at any age. The size and length of the patch varies from person to person. This condition tends to persist for years, with pores and large areas of skin losing color. However, in some affected individuals, plaques may remain stable or even develop.
In the absence of other autoimmune diseases, vitiligo does not affect health or physical function. However, issues related to appearance and race are a significant issue for many stakeholders. Vitiligo is often considered an autoimmune disease. Autoimmune diseases occur when the immune system attacks the body’s own tissues and organs. In people with vitiligo, the immune system appears to attack the pores and pigment cells (melanocytes) in the skin. About 15% to 25% of people with vitiligo have at least one autoimmune disease, specifically autoimmune thyroid disease, rheumatoid arthritis, type 1 diabetes, psoriasis, pernicious anemia, Addison’s disease, lupus, celiac disease, Crohn’s disease, or ulcerative disease. Stomach ache.
The main symptom of vitiligo is a lack of color or pigmentation, called depigmentation. Mild depigmentation can occur anywhere on the body and can affect:
The skin on the hands, feet, arms and face often appears white. But plaques can appear anywhere.
The hair turns gray where the skin loses its color. This condition can occur on the scalp, eyebrows, eyelashes, beard and body hair.
Like the mouth or nose.
Vitiligo patients may also experience the following:
Self-esteem due to low self-esteem or concerns about appearance can affect quality of life.
Uveitis is a general term describing inflammation or pain in the eye.